The potential cost-effectiveness of glycopyrronium bromide, a novel LAMA

被引:0
作者
Baldwin, Michael
Thuresson, Per-Olof
Asukai, Yumi
机构
[1] Novartis Pharmaceut UK Ltd, HEOR, Horsham RH12 5AB, W Sussex, England
[2] IMS Hlth, HEOR, Basel, Switzerland
[3] IMS Hlth, HEOR, London, England
关键词
COPD; -; management; Health policy; Quality of life;
D O I
暂无
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
2252
引用
收藏
页数:1
相关论文
empty
未找到相关数据